Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.
Methods. 2020 Aug 1;180:111-126. doi: 10.1016/j.ymeth.2020.05.006. Epub 2020 May 15.
Complex integral membrane proteins, which are embedded in the cell surface lipid bilayer by multiple transmembrane spanning helices, encompass families of proteins which are important target classes for drug discovery. These protein families include G protein-coupled receptors, ion channels and transporters. Although these proteins have typically been targeted by small molecule drugs and peptides, the high specificity of monoclonal antibodies offers a significant opportunity to selectively modulate these target proteins. However, it remains the case that isolation of antibodies with desired pharmacological function(s) has proven difficult due to technical challenges in preparing membrane protein antigens suitable to support antibody drug discovery. In this review recent progress in defining strategies for generation of membrane protein antigens is outlined. We also highlight antibody isolation strategies which have generated antibodies which bind the membrane protein and modulate the protein function.
复杂的整合膜蛋白通过多个跨膜螺旋嵌入细胞表面的脂质双层,包含了一系列对药物发现非常重要的蛋白家族。这些蛋白家族包括 G 蛋白偶联受体、离子通道和转运体。尽管这些蛋白通常是小分子药物和肽的靶点,但单克隆抗体的高特异性为选择性调节这些靶蛋白提供了重要机会。然而,由于制备适合支持抗体药物发现的膜蛋白抗原的技术挑战,仍然存在难以分离具有所需药理功能的抗体的问题。在这篇综述中,概述了定义生成膜蛋白抗原策略的最新进展。我们还强调了产生与膜蛋白结合并调节其功能的抗体的抗体分离策略。